SCHEMBL184923

SCHEMBL184923

CCOC(=O)C1CCN(c2cnc(N)s2)CC1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 2/20 0.54
ALDH1A1 P00352 3/20 0.50
NPC1 O15118 1/20 0.50
MAPT P10636 3/20 0.49
KMT2A Q03164 3/20 0.49
RAB9A P51151 1/20 0.49
POLB P06746 1/20 0.49
F10 P00742 1/20 0.49
PTPN11 Q06124 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
SHMT2 P34897 1/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL595764 0.81 PTPN11 (0.59) LGMNALDH1A1NPC1MAPTKMT2A
SCHEMBL3772589 0.81 SMN1; SMN2 (0.68) ALDH1A1MAPTKMT2APOLBSMN1; SMN2
SCHEMBL3766900 0.80 KDM4E (0.54) F10CYP2C19
SCHEMBL595334 0.78 SHMT2 (0.59) LGMNALDH1A1MAPTKMT2APOLB
SCHEMBL16323911 0.77 ALDH1A1 (0.67) LGMNALDH1A1NPC1MAPTKMT2A
SCHEMBL1024938 0.76 SMN1; SMN2 (0.47) LGMNALDH1A1NPC1KMT2ASMN1; SMN2
SCHEMBL2574241 0.76 ALDH1A1 (0.54) LGMNALDH1A1NPC1MAPTKMT2A
SCHEMBL195417 0.76 KDM4E (0.60) ALDH1A1MAPTKMT2ARAB9APOLB
SCHEMBL20564967 0.75 PTPN11 (0.53) LGMNALDH1A1MAPTKMT2ARAB9A
SCHEMBL3786436 0.75 KMT2A (0.55) LGMNALDH1A1NPC1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP disclosed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP disclosed